Optimizing care for young cancer patients with gastrointestinal tumors
JUMP_START - Optimization of Care for Young Cancer Patients with Gastrointestinal Tumors
This study is trying to understand the needs of young cancer patients with gastrointestinal tumors to improve their care and support services.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 250 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital Heidelberg Academic / other |
| Locations | 1 site (Heidelberg, Baden-Wurttemberg) |
| Trial ID | NCT06621277 on ClinicalTrials.gov |
What this trial studies
JUMP_START focuses on understanding the needs of individuals aged 50 and younger who are diagnosed with gastrointestinal tumors. The study involves conducting semi-structured telephone interviews to gather insights into their life situations and care experiences. Additionally, it will analyze the care networks of these young patients compared to older patients to identify gaps and improve support services. Based on the findings, tailored counseling programs will be developed to enhance the quality of care for this demographic.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 18 to 50 years who are currently receiving treatment for a gastrointestinal tumor at the Heidelberg University Hospital.
Not a fit: Patients diagnosed with gastrointestinal tumors after the age of 50 may not receive direct benefits from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve the quality of life and support for young cancer patients with gastrointestinal tumors.
How similar studies have performed: While this approach is tailored specifically for young patients with gastrointestinal tumors, similar studies focusing on optimizing care for specific age groups in cancer treatment have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals aged ≥ 18 and ≤ 50 years receiving treatment for a GI tumor at the Heidelberg University Hospital * Sufficient knowledge of the German language * Capable of providing informed consent * Additional recruitment for Phase 1B and Quality of Life assessments: Patients with GI tumor aged ≥ 51 years Exclusion Criteria: * Individuals with a GI tumor diagnosis after the age of 50 (except in Phase 1B and for Quality of Life assessments) * Individuals with a GI tumor diagnosis under the age of 18 * Lack of capacity to consent and/or absence of informed consent * Insufficient knowledge of the German language * Severe cognitive impairments
Where this trial is running
Heidelberg, Baden-Wurttemberg
- National Center for Tumor Diseases (NCT) Heidelberg — Heidelberg, Baden-Wurttemberg, Germany (Recruiting)
Study contacts
- Study coordinator: Bruno C. Köhler
- Email: jump-start.nct@med.uni-heidelberg.de
- Phone: +49 6221 5635676
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.